205 related articles for article (PubMed ID: 23140942)
21. Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010.
Head MG; Fitchett JR; Moore DA; Atun R
JRSM Open; 2015 Mar; 6(3):2054270415577056. PubMed ID: 25893108
[TBL] [Abstract][Full Text] [Related]
22. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Atun R
BMJ Open; 2013 Dec; 3(12):e003362. PubMed ID: 24327360
[TBL] [Abstract][Full Text] [Related]
23. Are the Norwegian health research investments in line with the disease burden?
Kinge JM; Roxrud I; Vollset SE; Skirbekk V; Røttingen JA
Health Res Policy Syst; 2014 Nov; 12():64. PubMed ID: 25427859
[TBL] [Abstract][Full Text] [Related]
24. Infectious disease research investments follow colonial ties: questionable ethics.
Fitchett JR; Head MG; Atun R
Int Health; 2014 Mar; 6(1):74-6. PubMed ID: 24464047
[TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010.
Head MG; Fitchett JR; Atun R
J R Soc Med; 2014 Mar; 107(3):110-5. PubMed ID: 24262891
[TBL] [Abstract][Full Text] [Related]
26. Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis.
Head MG; Goss S; Gelister Y; Alegana V; Brown RJ; Clarke SC; Fitchett JRA; Atun R; Scott JAG; Newell ML; Padmadas SS; Tatem AJ
Lancet Glob Health; 2017 Aug; 5(8):e772-e781. PubMed ID: 28668230
[TBL] [Abstract][Full Text] [Related]
27. A systematic analysis of UK cancer research funding by gender of primary investigator.
Zhou CD; Head MG; Marshall DC; Gilbert BJ; El-Harasis MA; Raine R; O'Connor H; Atun R; Maruthappu M
BMJ Open; 2018 Apr; 8(4):e018625. PubMed ID: 29712689
[TBL] [Abstract][Full Text] [Related]
28. Limited alignment of publicly competitive disease funding with disease burden in Japan.
Nomura S; Yoneoka D; Tanaka S; Makuuchi R; Sakamoto H; Ishizuka A; Nakamura H; Kubota A; Shibuya K
PLoS One; 2020; 15(2):e0228542. PubMed ID: 32040510
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between disease burden and research funding through the Health Research Foundation in Spain].
Gómez-García T; Moreno-Casbas T; González-María E; Fuentelsaz-Gallego C
Enferm Clin; 2014; 24(4):219-32. PubMed ID: 24819151
[TBL] [Abstract][Full Text] [Related]
30. Global health priorities and research funding.
Ghinai I; Hla TT; Smith R
Lancet Infect Dis; 2013 Aug; 13(8):653. PubMed ID: 23886329
[No Abstract] [Full Text] [Related]
31. Global health priorities and research funding.
Catalá-López F; Gènova-Maleras R; Peiró S
Lancet Infect Dis; 2013 Aug; 13(8):652. PubMed ID: 23886327
[No Abstract] [Full Text] [Related]
32. National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease.
Chinnery F; Bashevoy G; Blatch-Jones A; Douet L; Puddicombe S; Raftery J
Trials; 2018 Feb; 19(1):87. PubMed ID: 29394905
[TBL] [Abstract][Full Text] [Related]
33. Global health priorities and research funding--authors' reply.
Head MG; Fitchett JR; Atun R
Lancet Infect Dis; 2013 Aug; 13(8):653. PubMed ID: 23886328
[No Abstract] [Full Text] [Related]
34. Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013.
Head MG; Fitchett JR; Lichtman AB; Soyode DT; Harris JN; Atun R
J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S3-7. PubMed ID: 26744430
[TBL] [Abstract][Full Text] [Related]
35. Mapping the terrain of investment in global infectious diseases.
Kyratsis Y; Ahmad R
Lancet Infect Dis; 2013 Jan; 13(1):6-7. PubMed ID: 23140943
[No Abstract] [Full Text] [Related]
36. Global public and philanthropic investment in childhood cancer research: systematic analysis of research funding, 2008-16.
Loucaides EM; Fitchett EJA; Sullivan R; Atun R
Lancet Oncol; 2019 Dec; 20(12):e672-e684. PubMed ID: 31797794
[TBL] [Abstract][Full Text] [Related]
37. Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019.
Ballreich JM; Gross CP; Powe NR; Anderson GF
JAMA Netw Open; 2021 Jan; 4(1):e2034890. PubMed ID: 33502486
[TBL] [Abstract][Full Text] [Related]
38. Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Mokdad AH; Forouzanfar MH; Daoud F; Mokdad AA; El Bcheraoui C; Moradi-Lakeh M; Kyu HH; Barber RM; Wagner J; Cercy K; Kravitz H; Coggeshall M; Chew A; O'Rourke KF; Steiner C; Tuffaha M; Charara R; Al-Ghamdi EA; Adi Y; Afifi RA; Alahmadi H; AlBuhairan F; Allen N; AlMazroa M; Al-Nehmi AA; AlRayess Z; Arora M; Azzopardi P; Barroso C; Basulaiman M; Bhutta ZA; Bonell C; Breinbauer C; Degenhardt L; Denno D; Fang J; Fatusi A; Feigl AB; Kakuma R; Karam N; Kennedy E; Khoja TA; Maalouf F; Obermeyer CM; Mattoo A; McGovern T; Memish ZA; Mensah GA; Patel V; Petroni S; Reavley N; Zertuche DR; Saeedi M; Santelli J; Sawyer SM; Ssewamala F; Taiwo K; Tantawy M; Viner RM; Waldfogel J; Zuñiga MP; Naghavi M; Wang H; Vos T; Lopez AD; Al Rabeeah AA; Patton GC; Murray CJ
Lancet; 2016 Jun; 387(10036):2383-401. PubMed ID: 27174305
[TBL] [Abstract][Full Text] [Related]
39. The anatomy of medical research: US and international comparisons.
Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
[TBL] [Abstract][Full Text] [Related]
40. Resource allocation for biomedical research: analysis of investments by major funders.
Ralaidovy AH; Adam T; Boucher P
Health Res Policy Syst; 2020 Feb; 18(1):20. PubMed ID: 32066463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
